A randomized phase II trial of cabozantinib combined with PD-1 and CTLA-4 inhibition in metastatic soft tissue sarcoma.

Academic Article


Published In


  • Clinical Research, Rare Diseases, Clinical Trials and Supportive Activities, Cancer, Orphan Drug, 6.1 Pharmaceuticals, 6 Evaluation of treatments and therapeutic interventions, 6.2 Cellular and gene therapies, Cancer
  • Digital Object Identifier (doi)

    Author List

  • Eulo VA; Wilky BA; Luo J; Hirbe AC; Weiss MC; Oppelt PJ; Abaricia S; Toeniskoetter J; Ruff T; Maki RG
  • Start Page

  • tps11583
  • End Page

  • tps11583
  • Volume

  • 39
  • Issue

  • 15_suppl